Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $2.42 Million - $2.69 Million
-10,368 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $85,435 - $99,561
385 Added 3.86%
10,368 $2.58 Million
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $9,620 - $10,698
-41 Reduced 0.41%
9,983 $2.54 Million
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $205,524 - $252,206
-1,039 Reduced 9.39%
10,024 $2.36 Million
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $178,048 - $236,140
977 Added 9.69%
11,063 $2.24 Million
Q4 2019

Feb 18, 2020

SELL
$189.21 - $243.2 $93,848 - $120,627
-496 Reduced 4.69%
10,086 $2.43 Million
Q3 2019

Nov 14, 2019

BUY
$174.11 - $208.62 $116,827 - $139,984
671 Added 6.77%
10,582 $2.05 Million
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $650,130 - $762,099
-3,900 Reduced 28.24%
9,911 $1.83 Million
Q1 2019

May 15, 2019

SELL
$180.87 - $203.88 $49,558 - $55,863
-274 Reduced 1.95%
13,811 $2.62 Million
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $33,896 - $39,567
190 Added 1.37%
14,085 $2.74 Million
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $39,281 - $44,284
-212 Reduced 1.5%
13,895 $2.88 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $58,615 - $65,838
353 Added 2.57%
14,107 $2.6 Million
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $237,879 - $277,992
-1,404 Reduced 9.26%
13,754 $2.35 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $5,907 - $6,600
35 Added 0.23%
15,158 $2.64 Million
Q2 2017

Aug 14, 2017

BUY
N/A
15,123
15,123 $2.61 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Capital Bank & Trust CO Portfolio

Follow Capital Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Capital Bank & Trust CO with notifications on news.